Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for ORLISTAT
- A Phase 1 Study to Evaluate EMP22 PD and EMP16 PK Versus Xenical® in Healthy Volunteers
- Long Term Efficacy and Safety of Orlistat for Type 1 Hyperlipoproteinemia
- Study on the Efficacy and Safety of Chiglitazar Sodium in PCOS With T2DM
- A Research Study Comparing Wegovy to Other Weight Management Drugs in People Living With Obesity in America
- Orlistat Reduces Uric Acid in Overweight/Obese Patients With Hyperuricemia
- Pharmacodynamic Equivalence Study Of Orlistat Capsules 60 mg
- Pharmacotherapy for Pediatric Obesity: A Phentermine Clinical Trial
- Comparing a Virtual vs. Face to Face Weight Management Program Using Phentermine for Patients With Overweight or Obesity
- EMI-EHP Weight Management and Type 2 Diabetes Pragmatic Trial
- A Proof of Concept Trial in Overweight and Obese Patients, Investigating Effect of EMP16-02 on Body Weight (Primary)
- Role of Pharmacotherapy in Counteracting Weight Regain in Adolescents With Severe Obesity
- Orlistat/Phentermine Versus Placebo/Phentermine
- Weight Loss Aid in an Exposed Population
- Research of Intensive Metabolic Intervention Before Pregnancy in PCOS
- An Add-on Study of MLR-1023 in Adults With Uncontrolled Type 2 Diabetes on Metformin Therapy
- Fixed Dose Combination of Fluoxetin and Metformin in the Management of Overweight and Obesity
- Saxenda in Obesity Services (STRIVE Study)
- Orlistat for the Treatment of Type I Hyperlipoproteinemia
- Multifactorial Approach Associated With Orlistat (Xenical) for 4 Years Weight Loss Maintenance in Obese Adults
- RCT to Compare Orlistat and Polyglucosamine for the Management of Overweight and Obesity
- Improving Reproductive Fitness Through Pretreatment With Lifestyle Modification in Obese Women With Unexplained Infertility
- Risk Management Plan (RMP) Survey for Purchasers of Alli® (60 mg Orlistat) in the European Union.
- Ketogenic Diet Treatment of Obesity With Co-morbid Type 2 Diabetes Mellitus and/or Obstructive Sleep Apnea
- Effects of Liraglutide in Young Adults With Type 2 DIAbetes (LYDIA)
- Roux-en-Y Gastric Bypass for BMI 27-32 Type 2 Diabetes Versus Best Medical Treatment
- Therapeutic Equivalence Between Branded and Generic WARFArin Tablets in Brazil
- Topiramate in Adolescents With Severe Obesity
- Comparison of MAG and Fish Oil Efficacy
- Evaluation of Orlistat as Adjuvant Treatment of Obesity in Adults
- The Effect of Modified Sham Feeding With Orlistat in Overweight and Obese Subjects
- Phase 2 Study of Orlistat and SLx-4090 for the Treatment of Type 1 Hyperlipoproteinemia
- Combinatorial Therapy for Peristent Type 2 Diabetes After Gastric Banding
- A Study to Assess the Pharmacologic Equivalence of Two Orlistat Dosage Forms
- The Effect of Weight Loss on Anti-Müllerian Hormone Levels in Women With Polycystic Ovary Syndrome (PCOS)
- Orlistat Induced Modulation on the Fatty Acid Composition in Obese Females
- Survey on the Pharmacy Follow-up of Alli Purchasers
- Drug Therapy Induced Weight Loss to Improve Blood Vessel Function in Subjects With Obesity
- Meta-analysis of Orlistat Laboratory Data From Placebo-controlled Clinical Trials
- Assess the Additional Weight Loss Effect of Orlistat Used in Combination With Sibutramine
- Study of Fat Malabsorption by Lipiblock Versus Xenical
- Double-Blind, Multi-Center, Randomized Study to Assess the Efficacy and Safety of Velneperit (S-2367) and Orlistat Administered Individually or Combined With a Reduced Calorie Diet (RCD) in Obese Subjects
- A Pilot Study of the Efficacy of Alli in the Management of Pre-operative Weight Loss Required for Bariatric Surgery.
- Metformin Versus Orlistat in Obese Polycystic Ovary Syndrome (PCOS) Patients
- Prevalence of Non-alcoholic Fatty Liver Disease (NAFLD) in Hispanics With Diabetes Mellitus Type 2 (T2DM) and Role of Treatment
- Growth Factor/Insulin-like Growth Factor (GH/IGF)-1 Axis in Obese Subjects in Treatment With Orlistat
- A Study of Xenical (Orlistat) in Overweight and Obese Adolescents
- Increasing Cure Rate of Hepatitis C Therapy in Obese Hepatitis C Patients
- Treatment of Obesity and Binge Eating: Behavioral Weight Loss Versus Stepped Care
- Aggressive Treatment of Metabolic Syndrome in Patients Receiving Clozapine for Schizophrenia
- Chromium Piccolinate in the Prevention of Weight Gain Induced by Serotonergic Medications Initiated on Psychiatric Inpatient Units.
- Effect of Orlistat in Body Composition
- Treatment of Hyperandrogenism Versus Insulin Resistance in Infertile Polycystic Ovary Syndrome (PCOS) Women
- Adding Guided Self-Help Group Therapy to the Alli Weight Loss Program in Treating Binge Eating Disorder
- Efficacy of MK0557 in Combination With Sibutramine or Orlistat (0557-015)(COMPLETED)
- Study of Behavioral Weight Loss Therapy for Obesity and Binge Eating in Monolingual Hispanic Persons
- Orlistat Treatment of Crigler-Najjar Disease
- The Effect of Liraglutide on Body Weight in Obese Subjects Without Diabetes
- An RCT of Metformin Vs Orlistat in Obese Anovulatory Women
- Effectiveness of Brief Counseling for Weight Management
- Orlistat (Xenical) in the Treatment of Overweight Patients With Nonalcoholic Steatohepatitis (NASH)
- Efficacy and Safety of ATL-962 in Obese Diabetics
- The Effect of Xenical on Weight and Risk Factors
- A Low-Carbohydrate, Ketogenic Diet Versus Orlistat for Weight Loss
- Safety and Efficacy of Xenical in Children and Adolescents With Obesity-Related Diseases
Clinical trials list
click for details